Fonterra’s Strategic Placement of Probiotics

Since the 1990s, Fonterra has initiated large-scale probiotic research and now has a global library of mega strains of dairy fermenting bacteria, with a total number of over 40,000 strains. With over twenty years of preparation, Fonterra gained two-star strains that can be used in baby foods: SureStart HN001 Lactobacillus rhamnosus and SureStart HN019 Bifidobacterium lactis. In the current “down” time for the mother and baby industry, probiotics, which are expected to reach about RMB 90 billion yuan (USD $14 billion) market size in 2022, could be the hope for this industry. (Source: baijiahao)